Advertisement
JUNS vs NAGE
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JUNS is a Hold and NAGE is a StrongBuy.
JUNS sees its 50-day moving average cross bearishly below its 200-day moving average
The 50-day moving average for JUNS moved below the 200-day moving average on October 13, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on JUNS as a result. In 24 of 28 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where JUNS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
JUNS broke above its upper Bollinger Band on October 13, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for JUNS entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +17.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where JUNS advanced for three days, in 65 of 80 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-9.548) is normal, around the industry mean (2.973). P/E Ratio (-0.142) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (22.831) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 93 (best 1 - 100 worst), indicating slightly worse than average price growth. JUNS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. JUNS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
NAGE's Stochastic Oscillator is sitting in oversold zone for 17 days
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where NAGE's RSI Oscillator exited the oversold zone, 27 of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.
Following a +0.80% 3-day Advance, the price is estimated to grow further. Considering data from situations where NAGE advanced for three days, in 189 of 250 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
NAGE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NAGE as a result. In 87 of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
The Moving Average Convergence Divergence Histogram (MACD) for NAGE turned negative on September 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 45 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NAGE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Aroon Indicator for NAGE entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 25 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.416) is normal, around the industry mean (1.728). P/E Ratio (12.600) is within average values for comparable stocks, (6.556). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.458). Dividend Yield (0.000) settles around the average of (0.056) among similar stocks. P/S Ratio (1.976) is also within normal values, averaging (4.925).
The Tickeron Price Growth Rating for this company is 85 (best 1 - 100 worst), indicating slightly worse than average price growth. NAGE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NAGE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
NAGE | ||
|---|---|---|
OUTLOOK RATING 1..100 | 72 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 63 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 45 | |
PRICE GROWTH RATING 1..100 | 85 | |
P/E GROWTH RATING 1..100 | 93 | |
SEASONALITY SCORE 1..100 | 25 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| JUNS | NAGE | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 79% |
| Stochastic ODDS (%) | 1 day ago 84% | 1 day ago 81% |
| Momentum ODDS (%) | 1 day ago 86% | 1 day ago 88% |
| MACD ODDS (%) | N/A | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 90% | 1 day ago 86% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 85% |
| Advances ODDS (%) | 10 days ago 81% | 3 days ago 76% |
| Declines ODDS (%) | 1 day ago 90% | 9 days ago 83% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 73% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 82% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
JUNS’s FA Score shows that 1 FA rating(s) are green while NAGE’s FA Score has 0 green FA rating(s).
- JUNS’s FA Score: 1 green, 4 red.
- NAGE’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
JUNS’s TA Score shows that 2 TA indicator(s) are bullish while NAGE’s TA Score has 4 bullish TA indicator(s).
- JUNS’s TA Score: 2 bullish, 5 bearish.
- NAGE’s TA Score: 4 bullish, 4 bearish.
Price Growth
JUNS (@Biotechnology) experienced а -12.85% price change this week, while NAGE (@Food: Major Diversified) price change was -2.37% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.
The average weekly price growth across all stocks in the @Food: Major Diversified industry was -1.66%. For the same industry, the average monthly price growth was -8.75%, and the average quarterly price growth was -18.11%.
Reported Earning Dates
JUNS is expected to report earnings on Nov 13, 2026.
NAGE is expected to report earnings on Nov 04, 2026.
Industries' Descriptions
@Biotechnology (-1.10% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
@Food: Major Diversified (-1.66% weekly)Companies in this industry usually make a diverse range of agricultural and/or processed food. Some prominent names in this segment are Mondelez International, which makes chocolates, biscuits, cookies etc. The Kraft Heinz Company specializes in ketchups, sauces, fruit drink pouches and many more. General Mills, Inc. sells flour and cereal. Kellogg is famous for its snacks and breakfast cereal. And so on down the line. As more and more consumers are looking for healthier options in food in recent years, several legacy food companies have responded by revamping brands to include organic and no-added-sugar versions, and/or acquiring healthy food firms, and even streamlining operations.
Advertisement
JUNS and
Correlation & Price change
A.I.dvisor tells us that JUNS and DNA have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JUNS and DNA's prices will move in lockstep.
| Ticker / NAME | Correlation To JUNS | 1D Price Change % | ||
|---|---|---|---|---|
| JUNS | 100% | -4.68% | ||
| DNA - JUNS | 24% Poorly correlated | -3.00% | ||
| NAGE - JUNS | 23% Poorly correlated | +2.02% | ||
| KZIA - JUNS | 22% Poorly correlated | -1.34% | ||
| RXRX - JUNS | 22% Poorly correlated | -1.65% | ||
| ONCY - JUNS | 21% Poorly correlated | -2.19% | ||
More | ||||
NAGE and
Correlation & Price change
A.I.dvisor indicates that over the last year, NAGE has been loosely correlated with AXON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if NAGE jumps, then AXON could also see price increases.
| Ticker / NAME | Correlation To NAGE | 1D Price Change % | ||
|---|---|---|---|---|
| NAGE | 100% | +2.02% | ||
| AXON - NAGE | 43% Loosely correlated | +2.98% | ||
| USNA - NAGE | 39% Loosely correlated | +2.11% | ||
| TRDA - NAGE | 38% Loosely correlated | +1.72% | ||
| AMRN - NAGE | 35% Loosely correlated | +0.78% | ||
| CYTK - NAGE | 35% Loosely correlated | -0.84% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GLIX | 27.16 | 0.47 | +1.78% |
| Lazard Listed Infrastructure ETF (GLIX) | |||
| NMCO | 8.81 | 0.07 | +0.80% |
| Nuveen Municipal Credit Opportunities Fund | |||
| MYCM | 23.73 | 0.18 | +0.74% |
| State Street My2033 Corporate Bond ETF (MYCM) | |||
| COMB | 28.16 | -0.03 | -0.10% |
| GraniteShares Bloomberg Commodity Broad Strategy No K-1 ETF (COMB) | |||
| FLJP | 40.28 | -0.44 | -1.08% |
| Franklin FTSE Japan ETF (FLJP) | |||